Follow
HAMIDREZA GHANDEHARI
HAMIDREZA GHANDEHARI
Professor
Verified email at pharm.utah.edu - Homepage
Title
Cited by
Cited by
Year
Nanoparticle uptake: the phagocyte problem
HH Gustafson, D Holt-Casper, DW Grainger, H Ghandehari
Nano today 10 (4), 487-510, 2015
12222015
Impact of silica nanoparticle design on cellular toxicity and hemolytic activity
T Yu, A Malugin, H Ghandehari
ACS nano 5 (7), 5717-5728, 2011
7162011
Polymeric conjugates for drug delivery
N Larson, H Ghandehari
Chemistry of Materials 24 (5), 840-853, 2012
6592012
Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages
MM Arnida, A Ray, CM Peterson, H Ghandehari
European Journal of Pharmaceutics and Biopharmaceutics 77 (3), 417-423, 2011
5232011
Cellular uptake and toxicity of gold nanoparticles in prostate cancer cells: a comparative study of rods and spheres
Arnida, A Malugin, H Ghandehari
Journal of Applied Toxicology: An International Journal 30 (3), 212-217, 2010
4212010
Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability
RB Kolhatkar, KM Kitchens, PW Swaan, H Ghandehari
Bioconjugate chemistry 18 (6), 2054-2060, 2007
3452007
Transepithelial transport and toxicity of PAMAM dendrimers: implications for oral drug delivery
S Sadekar, H Ghandehari
Advanced drug delivery reviews 64 (6), 571-588, 2012
3432012
Nanoparticle geometry and surface orientation influence mode of cellular uptake
H Herd, N Daum, AT Jones, H Huwer, H Ghandehari, CM Lehr
ACS nano 7 (3), 1961-1973, 2013
3392013
Transepithelial transport of poly (amidoamine) dendrimers across Caco-2 cell monolayers
M El-Sayed, M Ginski, C Rhodes, H Ghandehari
Journal of controlled release 81 (3), 355-365, 2002
3282002
Mechanisms and barriers in cancer nanomedicine: addressing challenges, looking for solutions
TJ Anchordoquy, Y Barenholz, D Boraschi, M Chorny, P Decuzzi, ...
ACS nano 11 (1), 12-18, 2017
3092017
Genetically engineered silk-elastinlike protein polymers for controlled drug delivery
Z Megeed, J Cappello, H Ghandehari
Advanced drug delivery reviews 54 (8), 1075-1091, 2002
3012002
Cellular uptake and cytotoxicity of silica nanotubes
A Nan, X Bai, SJ Son, SB Lee, H Ghandehari
Nano letters 8 (8), 2150-2154, 2008
2662008
In vitro and in vivo evaluation of recombinant silk-elastinlike hydrogels for cancer gene therapy
Z Megeed, M Haider, D Li, BW O'Malley Jr, J Cappello, H Ghandehari
Journal of Controlled Release 94 (2-3), 433-445, 2004
2442004
Influence of geometry, porosity, and surface characteristics of silica nanoparticles on acute toxicity: their vasculature effect and tolerance threshold
T Yu, K Greish, LD McGill, A Ray, H Ghandehari
ACS nano 6 (3), 2289-2301, 2012
2262012
Endocytosis and interaction of poly (amidoamine) dendrimers with Caco-2 cells
KM Kitchens, AB Foraker, RB Kolhatkar, PW Swaan, H Ghandehari
Pharmaceutical research 24, 2138-2145, 2007
2162007
Transepithelial and endothelial transport of poly (amidoamine) dendrimers
KM Kitchens, MEH El-Sayed, H Ghandehari
Advanced drug delivery reviews 57 (15), 2163-2176, 2005
2162005
Cationic PAMAM dendrimers aggressively initiate blood clot formation
CF Jones, RA Campbell, AE Brooks, S Assemi, S Tadjiki, G Thiagarajan, ...
ACS nano 6 (11), 9900-9910, 2012
2102012
In vivo biodistribution and pharmacokinetics of silica nanoparticles as a function of geometry, porosity and surface characteristics
T Yu, D Hubbard, A Ray, H Ghandehari
Journal of controlled release 163 (1), 46-54, 2012
2102012
Transport of poly (amidoamine) dendrimers across Caco-2 cell monolayers: influence of size, charge and fluorescent labeling
KM Kitchens, RB Kolhatkar, PW Swaan, ND Eddington, H Ghandehari
Pharmaceutical research 23, 2818-2826, 2006
2092006
Targeting tumor angiogenic vasculature using polymer–RGD conjugates
A Mitra, J Mulholland, A Nan, E McNeill, H Ghandehari, BR Line
Journal of Controlled Release 102 (1), 191-201, 2005
2002005
The system can't perform the operation now. Try again later.
Articles 1–20